ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Rovalpituzumab Biosimilar - Anti-DLL3 Antibody (Biotin) (A332023)

Recombinant humanized monoclonal antibody to DLL3 (Biotin) for ELISA and Flow Cytometry.

Alternative Formats and ConjugatesAlternative Formats

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 7-10 business days.
Name
Rovalpituzumab Biosimilar - Anti-DLL3 Antibody (Biotin)
Description
Recombinant humanized monoclonal antibody to DLL3 (Biotin).
Applications
ELISA, Flow Cytometry
Dilutions
ELISA 1:5,000-1:10,000, Flow Cytometry: 1:100
Reactivity
Human
Host
Humanized
Clonality
Monoclonal
Isotype
IgG1
Conjugate

Biotin

Purification
Affinity chromatography.
Concentration
Reconstitution dependent.
Product Form
Lyophilized
Reconstitution
Reconstitute with distilled sterile water.
Formulation
Lyophilized from sterile Phosphate Buffered Saline, pH 7.4. Normally 5%–8% Trehalose is added as a protectant before lyophilization.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
General Notes
Prior to reconstitution, centrifuge the vial at 5,000g for 3-5 minutes at room temperature. Reconstitute with appropriate volume of distilled sterile water to bring product to 1mg/ml concentration. After addition of distilled sterile water, mix by gentle tapping. Note: It is not recommended to vortex or vigorously pipette the sample.
Synonyms
Delta-like protein 3, Delta3, Drosophila Delta homolog 3
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Rovalpituzumab Biosimilar - Anti-DLL3 Antibody (Biotin) (A332023)? Please let us know so that we can list the citation on this page.

Alternative products to Rovalpituzumab Biosimilar - Anti-DLL3 Antibody (Biotin) (A332023)

Proteins predicted to interact with DLL3

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.8% Relevancy Score
99.8% Relevancy Score
99.8% Relevancy Score
99.8% Relevancy Score
94% Relevancy Score
91.9% Relevancy Score
86.7% Relevancy Score
85.7% Relevancy Score
84.8% Relevancy Score